MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202641050247 A) filed by Dr. Latha Kiran Krishna Rajendran, Bangalore, Karnataka, on April 20, for 'ai-optimized car-t cell engineering platforms for personalized immunotherapy.' Inventor(s) include Dr. Latha Kiran Krishna Rajendran. The application for the patent was published on May 1, under issue no. 18/2026. According to the abstract released by the Intellectual Property India: "Chimeric Antigen Recept...